{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:10:35Z","timestamp":1768522235134,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s12010-022-03928-2","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T12:03:05Z","timestamp":1651665785000},"page":"4511-4529","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Artificial Neural Network-Based Study Predicts GS-441524 as a Potential Inhibitor of SARS-CoV-2 Activator Protein Furin: a Polypharmacology Approach"],"prefix":"10.1007","volume":"194","author":[{"given":"M.","family":"Dhanalakshmi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kajari","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Medha","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sejal","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayushman","family":"Gadnayak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushma","family":"Dave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayashankar","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,4]]},"reference":[{"issue":"25","key":"3928_CR1","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1056\/NEJMms1706744","volume":"377","author":"JA Greene","year":"2017","unstructured":"Greene, J. A., & Loscalzo, J. (2017). Putting the patient back together \u2014 Social medicine, network medicine, and the limits of reductionism. The New England Journal of Medicine, 377(25), 2493\u20132499.","journal-title":"The New England Journal of Medicine"},{"issue":"10","key":"3928_CR2","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1007\/s12010-021-03608-7","volume":"193","author":"KK Bharadwaj","year":"2021","unstructured":"Bharadwaj, K. K., Sarkar, T., Ghosh, A., Baishya, D., Rabha, B., Panda, M. K., et al. (2021). Macrolactin A as a novel inhibitory agent for SARS-CoV-2 Mpro: Bioinformatics approach. Applied Biochemistry and Biotechnology, 193(10), 3371\u20133394.","journal-title":"Applied Biochemistry and Biotechnology"},{"issue":"8","key":"3928_CR3","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.31557\/APJCP.2021.22.8.2461","volume":"22","author":"T Juneja","year":"2021","unstructured":"Juneja, T., Pandya, M. D., & Shah, S. (2021). Molecular landscape and computational screening of the natural inhibitors against HPV16 E6 oncoprotein. Asian Pacific Journal of Cancer Prevention, 22(8), 2461.","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"issue":"1","key":"3928_CR4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2016.230","volume":"16","author":"R Santos","year":"2016","unstructured":"Santos, R., Ursu, O., Gaulton, A., Bento, A. P., Donadi, R. S., Bologa, C. G., et al. (2016). A comprehensive map of molecular drug targets. Nature Reviews. Drug Discovery, 16(1), 19\u201334.","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"4","key":"3928_CR5","first-page":"682","volume":"18","author":"F Cheng","year":"2017","unstructured":"Cheng, F., Hong, H., Yang, S., & Wei, Y. (2017). Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era. Briefings in Bioinformatics, 18(4), 682\u2013697.","journal-title":"Briefings in Bioinformatics"},{"key":"3928_CR6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-8868-6_15","volume":"2019","author":"F Cheng","year":"2019","unstructured":"Cheng, F. (2019). In silico oncology drug repositioning and polypharmacology. Methods in Molecular Biology, 2019, 243\u2013261.","journal-title":"Methods in Molecular Biology"},{"key":"3928_CR7","unstructured":"Bharadwaj, K.K., Sarkar, T., Ghosh, A., Baishya, D., Rabha, B., Bharadwaj, M. K.K. K., Sarkar, T., Ghosh, A., Baishya, D., Rabha, B., Panda, M. K., Nelson, B. R., John, A., Hassan S. P. Nature potential for COVID-19: Targeting SARS-CoV-2 Mpro Inhibitor with bioactive compound. Chemrxiv."},{"issue":"5","key":"3928_CR8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrd.2015.37","volume":"15","author":"A Zumla","year":"2016","unstructured":"Zumla, A., Chan, J. F. W., Azhar, E. I., Hui, D. S. C., & Yuen, K. Y. (2016). Coronaviruses-drug discovery and therapeutic options. Nature Reviews. Drug Discovery, 15(5), 327\u2013347.","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"2","key":"3928_CR9","doi-asserted-by":"crossref","first-page":"e0247115","DOI":"10.1371\/journal.pone.0247115","volume":"16","author":"RC Bhoyar","year":"2021","unstructured":"Bhoyar, R. C., Jain, A., Sehgal, P., Divakar, M. K., Sharma, D., Imran, M., et al. (2021). High throughput detection and genetic epidemiology of SARS-CoV-2 using COVIDSeq next-generation sequencing. PLoS One, 16(2), e0247115.","journal-title":"PLoS One"},{"key":"3928_CR10","doi-asserted-by":"crossref","unstructured":"Medha, P., Sejal, S., Dhanalakshmi, M, Tanzil Juneja A.P., Ayushman, G., Sushma, D., & Kajari Das, J. D. (2022). Unravelling Vitamin B12 as a potential inhibitor against SARS-CoV-2: A computational approach . Informatics in Medicine Unlocked, (30),\u00a0100951","DOI":"10.1016\/j.imu.2022.100951"},{"issue":"10","key":"3928_CR11","doi-asserted-by":"crossref","first-page":"101642","DOI":"10.1016\/j.isci.2020.101642","volume":"23","author":"C Wu","year":"2020","unstructured":"Wu, C., Zheng, M., Yang, Y., Gu, X., Yang, K., Li, M., et al. (2020). Furin: A potential therapeutic target for COVID-19. iScience., 23(10), 101642.","journal-title":"iScience."},{"issue":"6220","key":"3928_CR12","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n, M., Fagerberg, L., Hallstr\u00f6m, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., et al. (2015). Tissue-based map of the human proteome. Science (80-)., 347(6220), 1260419.","journal-title":"Science (80-)."},{"key":"3928_CR13","doi-asserted-by":"crossref","first-page":"BCI-S2049","DOI":"10.4137\/BCI.S2049","volume":"2","author":"SA Tian","year":"2009","unstructured":"Tian, S. A. (2009). 20 residues motif delineates the furin cleavage site and its physical properties may influence viral fusion. Biochem Insights., 2, BCI-S2049.","journal-title":"Biochem Insights."},{"issue":"2","key":"3928_CR14","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.3390\/ijms12021060","volume":"12","author":"S Tian","year":"2011","unstructured":"Tian, S., Huang, Q., Fang, Y., & Wu, J. (2011). FurinDB: A database of 20-residue furin cleavage site motifs, substrates and their associated drugs. International Journal of Molecular Sciences, 12(2), 1060\u20131065.","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"3928_CR15","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1021\/ci0600657","volume":"46","author":"P Selzer","year":"2006","unstructured":"Selzer, P., & Ertl, P. (2006). Applications of self-organizing neural networks in virtual screening and diversity selection. Journal of Chemical Information and Modeling, 46(6), 2319\u20132323.","journal-title":"Journal of Chemical Information and Modeling"},{"issue":"6","key":"3928_CR16","first-page":"2319","volume":"46","author":"P Schneider","year":"2008","unstructured":"Schneider, P., Tanrikulu, Y., & Schneider, G. (2008). Self-organizing maps in drug discovery: Compound library design, scaffold-hopping, repurposing. Current Medicinal Chemistry, 46(6), 2319\u20132323.","journal-title":"Current Medicinal Chemistry"},{"issue":"10","key":"3928_CR17","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10822-007-9145-8","volume":"21","author":"DP Hristozov","year":"2007","unstructured":"Hristozov, D. P., Oprea, T. I., & Gasteiger, J. (2007). Virtual screening applications: A study of ligand-based methods and different structure representations in four different scenarios. Journal of Computer-Aided Molecular Design, 21(10), 617\u2013640.","journal-title":"Journal of Computer-Aided Molecular Design"},{"issue":"6","key":"3928_CR18","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1021\/ci0500839","volume":"45","author":"XY De","year":"2005","unstructured":"De, X. Y., Clauset, A., Harris, R., Bayram, E., Santago, P., & Schmitt, J. D. (2005). Supervised self-organizing maps in drug discovery. 1. Robust behavior with overdetermined data sets. Journal of Chemical Information and Modeling, 45(6), 1749\u20131758.","journal-title":"Journal of Chemical Information and Modeling"},{"issue":"10","key":"3928_CR19","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/s41587-020-0686-x","volume":"38","author":"JM Levin","year":"2020","unstructured":"Levin, J. M., Oprea, T. I., Davidovich, S., Clozel, T., Overington, J. P., Vanhaelen, Q., et al. (2020). Artificial intelligence, drug repurposing and peer review. Nature Biotechnology, 38(10), 1127\u20131131.","journal-title":"Nature Biotechnology"},{"key":"3928_CR20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.compbiolchem.2017.07.005","volume":"70","author":"A Gad","year":"2017","unstructured":"Gad, A., Manuel, A. T., Jinuraj, K. R., John, L., Sajeev, R., Lijo, J., Sajeev, R., Shanmuga Priya, V. G., Abdul Jaleel, U. C., et al. (2017). Virtual screening and repositioning of inconclusive molecules of beta-lactamase bioassays\u2014A data mining approach. Computational Biology and Chemistry, 70, 65\u201388.","journal-title":"Computational Biology and Chemistry"},{"issue":"4","key":"3928_CR21","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/prot.20251","volume":"57","author":"E Krieger","year":"2004","unstructured":"Krieger, E., Darden, T., Nabuurs, S. B., Finkelstein, A., & Vriend, G. (2004). Making optimal use of empirical energy functions: Force-field parameterization in crystal space. Proteins: Structure, Function, and Genetics, 57(4), 678\u2013683.","journal-title":"Proteins: Structure, Function, and Genetics"},{"issue":"1","key":"3928_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13104-017-3088-5","volume":"11","author":"KR Jinuraj","year":"2018","unstructured":"Jinuraj, K. R., Rakhila, M., Dhanalakshmi, M., Sajeev, R., Akshata, G., Jayan, K., et al. (2018). Feature optimization in high dimensional chemical space: Statistical and data mining solutions. BMC Research Notes, 11(1), 1\u20137.","journal-title":"BMC Research Notes"},{"issue":"5","key":"3928_CR23","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1021\/acschembio.6b01110","volume":"12","author":"SO Dahms","year":"2017","unstructured":"Dahms, S. O., Jiao, G. S., & Than, M. E. (2017). Structural studies revealed active site distortions of human furin by a small molecule inhibitor. ACS Chemical Biology, 12(5), 1211\u20131216.","journal-title":"ACS Chemical Biology"},{"issue":"9","key":"3928_CR24","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1021\/tx200211v","volume":"24","author":"NA Meanwell","year":"2011","unstructured":"Meanwell, N. A. (2011). Improving drug candidates by design: A focus on physicochemical properties as a means of improving compound disposition and safety. Chemical Research in Toxicology, 24(9), 1420\u20131456.","journal-title":"Chemical Research in Toxicology"},{"issue":"1","key":"3928_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-02088-w","volume":"9","author":"F Cheng","year":"2018","unstructured":"Cheng, F., Desai, R. J., Handy, D. E., Wang, R., Schneeweiss, S., Barab\u00e1si, A. L., et al. (2018). Network-based approach to prediction and population-based validation of in silico drug repurposing. Nature Communications, 9(1), 1\u201312.","journal-title":"Nature Communications"},{"key":"3928_CR26","doi-asserted-by":"crossref","unstructured":"Pandya, M., Jani, S., Dave, V., & Rawal, R. (2020). Nanoinformatics: An emerging trend in cancer therapeutics. Nanobiotechnology: Concepts and Applications in Health, Agriculture, and Environment, 135.","DOI":"10.1201\/9780429292750-11"},{"key":"3928_CR27","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3389\/fmicb.2019.00886","volume":"10","author":"R Khandia","year":"2019","unstructured":"Khandia, R., Singhal, S., Kumar, U., Ansari, A., Tiwari, R., Dhama, K., et al. (2019). Analysis of Nipah virus codon usage and adaptation to hosts. Frontiers in Microbiology, 10, 886.","journal-title":"Frontiers in Microbiology"},{"issue":"1","key":"3928_CR28","first-page":"1","volume":"8","author":"KS Lata","year":"2018","unstructured":"Lata, K. S., Kumar, S., Vaghasia, V., Sharma, P., Bhairappanvar, S. B., Soni, S., et al. (2018). Exploring Leptospiral proteomes to identify potential candidates for vaccine design against Leptospirosis using an immunoinformatics approach. Scientific Reports, 8(1), 1\u201315.","journal-title":"Scientific Reports"},{"issue":"1","key":"3928_CR29","first-page":"217","volume":"8","author":"M Rakhila","year":"2018","unstructured":"Rakhila, M., Jinuraj, K. R., Dhanalakshmi, M., Reshmi, D., Manuel, A. T., & Jaleel, U. (2018). A decision making components in cyclisation of mannose derivatives\u2013A computational approach. IJRPC., 8(1), 217\u2013231.","journal-title":"IJRPC."},{"issue":"3","key":"3928_CR30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0079-6107(98)00026-1","volume":"70","author":"G Schneider","year":"1998","unstructured":"Schneider, G., & Wrede, P. (1998). Artificial neural networks for computer-based molecular design. Progress in Biophysics and Molecular Biology, 70(3), 175\u2013222.","journal-title":"Progress in Biophysics and Molecular Biology"},{"issue":"19","key":"3928_CR31","doi-asserted-by":"crossref","first-page":"7874","DOI":"10.1021\/jm5006463","volume":"57","author":"A Anighoro","year":"2014","unstructured":"Anighoro, A., Bajorath, J., & Rastelli, G. (2014). Polypharmacology: Challenges and opportunities in drug discovery: miniperspective. Journal of Medicinal Chemistry, 57(19), 7874\u20137887.","journal-title":"Journal of Medicinal Chemistry"},{"issue":"7","key":"3928_CR32","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.2174\/138161209788923967","volume":"15","author":"T Thepen","year":"2009","unstructured":"Thepen, T., Huhn, M., Melmer, G., Tur, M. K., & Barth, S. (2009). Fc\u03b3 receptor 1 (CD64), a target beyond cancer. Current Pharmaceutical Design, 15(7), 2712\u20132718.","journal-title":"Current Pharmaceutical Design"},{"issue":"6","key":"3928_CR33","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1182\/blood.V65.6.1318.bloodjournal6561318","volume":"65","author":"JL Murray","year":"1985","unstructured":"Murray, J. L., Loftin, K. C., Munn, C. G., Reuben, J. M., Mansell, P. W., & Hersh, E. M. (1985). Elevated adenosine deaminase and purine nucleoside phosphorylase activity in peripheral blood null lymphocytes from patients with acquired immune deficiency syndrome. Blood., 65(6), 1318\u20131324.","journal-title":"Blood."},{"issue":"2","key":"3928_CR34","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/jmv.25300","volume":"91","author":"X Tang","year":"2019","unstructured":"Tang, X., Yan, L., Li, H., Du, L., Shi, Y., Huang, F., et al. (2019). Increased expression of phosphoenolpyruvate carboxykinase cytoplasmic isoform by hepatitis B virus X protein affects hepatitis B virus replication. Journal of Medical Virology, 91(2), 258\u2013264.","journal-title":"Journal of Medical Virology"},{"issue":"7594","key":"3928_CR35","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature17180","volume":"531","author":"TK Warren","year":"2016","unstructured":"Warren, T. K., Jordan, R., Lo, M. K., Ray, A. S., Mackman, R. L., Soloveva, V., et al. (2016). Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature., 531(7594), 381\u2013385.","journal-title":"Nature."},{"issue":"4","key":"3928_CR36","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1021\/acs.jmedchem.0c01929","volume":"65","author":"Y Li","year":"2021","unstructured":"Li, Y., Cao, L., Li, G., Cong, F., Li, Y., Sun, J., et al. (2021). Remdesivir metabolite GS-441524 effectively inhibits SARS-CoV-2 infection in mouse models. Journal of Medicinal Chemistry, 65(4), 2785\u20132793.","journal-title":"Journal of Medicinal Chemistry"},{"issue":"1","key":"3928_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-86712-2","volume":"11","author":"SK Behera","year":"2021","unstructured":"Behera, S. K., Vhora, N., Contractor, D., Shard, A., Kumar, D., Kalia, K., et al. (2021). Computational drug repurposing study elucidating simultaneous inhibition of entry and replication of novel corona virus by Grazoprevir. Scientific Reports, 11(1), 1\u201311.","journal-title":"Scientific Reports"},{"issue":"7","key":"3928_CR38","doi-asserted-by":"crossref","first-page":"109133","DOI":"10.1016\/j.celrep.2021.109133","volume":"35","author":"K Bafna","year":"2021","unstructured":"Bafna, K., White, K., Harish, B., Rosales, R., Ramelot, T. A., Acton, T. B., et al. (2021). Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture. Cell Reports, 35(7), 109133.","journal-title":"Cell Reports"},{"key":"3928_CR39","doi-asserted-by":"crossref","unstructured":"Nguyenla, X., Wehri, E., Van Dis, E., Biering, S.B., Yamashiro, L.H., Stroumza J, (2020) et al. Discovery of SARS-CoV-2 antiviral synergy between remdesivir and approved drugs in human lung cells. bioRxiv.","DOI":"10.1101\/2020.09.18.302398"},{"key":"3928_CR40","doi-asserted-by":"crossref","unstructured":"Ni, X., Schro\u0308der, M., Olieric, V., Sharpe, M. E., Hernandez-Olmos, V., Proschak, E., ... & Chaikuad, A. (2021). Structural insights into plasticity and discovery of remdesivir metabolite GS-441524 binding in SARS-CoV-2 macrodomain. ACS Medicinal Chemistry Letters, 12(4), 603\u2013609.","DOI":"10.1021\/acsmedchemlett.0c00684"},{"issue":"6","key":"3928_CR41","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10930-020-09942-9","volume":"39","author":"LS Jung","year":"2020","unstructured":"Jung, L. S., Gund, T. M., & Narayan, M. (2020). Comparison of binding site of remdesivir and its metabolites with NSP12-NSP7-NSP8, and NSP3 of SARS CoV-2 virus and alternative potential drugs for COVID-19 treatment. The Protein Journal, 39(6), 619\u2013630.","journal-title":"The Protein Journal"},{"issue":"5","key":"3928_CR42","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s40262-021-00984-5","volume":"60","author":"R Humeniuk","year":"2021","unstructured":"Humeniuk, R., Mathias, A., Kirby, B. J., Lutz, J. D., Cao, H., Osinusi, A., et al. (2021). Pharmacokinetic, pharmacodynamic, and drug-interaction profile of remdesivir, a SARS-CoV-2 replication inhibitor. Clinical Pharmacokinetics, 60(5), 569\u2013583.","journal-title":"Clinical Pharmacokinetics"},{"issue":"5","key":"3928_CR43","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/cts.12815","volume":"13","author":"K Yang","year":"2020","unstructured":"Yang, K. (2020). What Do we know about remdesivir drug interactions? Clinical and Translational Science, 13(5), 842.","journal-title":"Clinical and Translational Science"},{"issue":"1","key":"3928_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s41061-020-00313-7","volume":"379","author":"D Li","year":"2021","unstructured":"Li, D., Hu, J., Li, D., Yang, W., Yin, S. F., & Qiu, R. (2021). Reviews on biological activity, clinical trial and synthesis progress of small molecules for the treatment of COVID-19. Topics in Current Chemistry, 379(1), 1\u201352.","journal-title":"Topics in Current Chemistry"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-022-03928-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-022-03928-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-022-03928-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T01:05:16Z","timestamp":1700528716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-022-03928-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,4]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["3928"],"URL":"https:\/\/doi.org\/10.1007\/s12010-022-03928-2","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,4]]},"assertion":[{"value":"4 May 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This manuscript does not contain any studies with human or animal participants performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors hereby agree to give their consent for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}